Cargando…
Outcomes of patients with stage I–II Hodgkin lymphoma who had uniform pre-treatment staging with PET/CT and treatment with limited field radiation therapy after chemotherapy
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9395516/ https://www.ncbi.nlm.nih.gov/pubmed/35995767 http://dx.doi.org/10.1038/s41408-022-00711-8 |
| _version_ | 1784771712296943616 |
|---|---|
| author | Frechette, Kelsey M. Lester, Scott C. Taparra, Kekoa Breen, William G. Martenson, James A. Hoppe, Bradford S. Peterson, Jennifer L. Rule, William G. Stafford, Scott L. Stish, Bradley J. Habermann, Thomas M. Young, Jason R. Harmsen, William S. Laack, Nadia N. |
| author_facet | Frechette, Kelsey M. Lester, Scott C. Taparra, Kekoa Breen, William G. Martenson, James A. Hoppe, Bradford S. Peterson, Jennifer L. Rule, William G. Stafford, Scott L. Stish, Bradley J. Habermann, Thomas M. Young, Jason R. Harmsen, William S. Laack, Nadia N. |
| author_sort | Frechette, Kelsey M. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9395516 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-93955162022-08-24 Outcomes of patients with stage I–II Hodgkin lymphoma who had uniform pre-treatment staging with PET/CT and treatment with limited field radiation therapy after chemotherapy Frechette, Kelsey M. Lester, Scott C. Taparra, Kekoa Breen, William G. Martenson, James A. Hoppe, Bradford S. Peterson, Jennifer L. Rule, William G. Stafford, Scott L. Stish, Bradley J. Habermann, Thomas M. Young, Jason R. Harmsen, William S. Laack, Nadia N. Blood Cancer J Correspondence Nature Publishing Group UK 2022-08-22 /pmc/articles/PMC9395516/ /pubmed/35995767 http://dx.doi.org/10.1038/s41408-022-00711-8 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Correspondence Frechette, Kelsey M. Lester, Scott C. Taparra, Kekoa Breen, William G. Martenson, James A. Hoppe, Bradford S. Peterson, Jennifer L. Rule, William G. Stafford, Scott L. Stish, Bradley J. Habermann, Thomas M. Young, Jason R. Harmsen, William S. Laack, Nadia N. Outcomes of patients with stage I–II Hodgkin lymphoma who had uniform pre-treatment staging with PET/CT and treatment with limited field radiation therapy after chemotherapy |
| title | Outcomes of patients with stage I–II Hodgkin lymphoma who had uniform pre-treatment staging with PET/CT and treatment with limited field radiation therapy after chemotherapy |
| title_full | Outcomes of patients with stage I–II Hodgkin lymphoma who had uniform pre-treatment staging with PET/CT and treatment with limited field radiation therapy after chemotherapy |
| title_fullStr | Outcomes of patients with stage I–II Hodgkin lymphoma who had uniform pre-treatment staging with PET/CT and treatment with limited field radiation therapy after chemotherapy |
| title_full_unstemmed | Outcomes of patients with stage I–II Hodgkin lymphoma who had uniform pre-treatment staging with PET/CT and treatment with limited field radiation therapy after chemotherapy |
| title_short | Outcomes of patients with stage I–II Hodgkin lymphoma who had uniform pre-treatment staging with PET/CT and treatment with limited field radiation therapy after chemotherapy |
| title_sort | outcomes of patients with stage i–ii hodgkin lymphoma who had uniform pre-treatment staging with pet/ct and treatment with limited field radiation therapy after chemotherapy |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9395516/ https://www.ncbi.nlm.nih.gov/pubmed/35995767 http://dx.doi.org/10.1038/s41408-022-00711-8 |
| work_keys_str_mv | AT frechettekelseym outcomesofpatientswithstageiiihodgkinlymphomawhohaduniformpretreatmentstagingwithpetctandtreatmentwithlimitedfieldradiationtherapyafterchemotherapy AT lesterscottc outcomesofpatientswithstageiiihodgkinlymphomawhohaduniformpretreatmentstagingwithpetctandtreatmentwithlimitedfieldradiationtherapyafterchemotherapy AT taparrakekoa outcomesofpatientswithstageiiihodgkinlymphomawhohaduniformpretreatmentstagingwithpetctandtreatmentwithlimitedfieldradiationtherapyafterchemotherapy AT breenwilliamg outcomesofpatientswithstageiiihodgkinlymphomawhohaduniformpretreatmentstagingwithpetctandtreatmentwithlimitedfieldradiationtherapyafterchemotherapy AT martensonjamesa outcomesofpatientswithstageiiihodgkinlymphomawhohaduniformpretreatmentstagingwithpetctandtreatmentwithlimitedfieldradiationtherapyafterchemotherapy AT hoppebradfords outcomesofpatientswithstageiiihodgkinlymphomawhohaduniformpretreatmentstagingwithpetctandtreatmentwithlimitedfieldradiationtherapyafterchemotherapy AT petersonjenniferl outcomesofpatientswithstageiiihodgkinlymphomawhohaduniformpretreatmentstagingwithpetctandtreatmentwithlimitedfieldradiationtherapyafterchemotherapy AT rulewilliamg outcomesofpatientswithstageiiihodgkinlymphomawhohaduniformpretreatmentstagingwithpetctandtreatmentwithlimitedfieldradiationtherapyafterchemotherapy AT staffordscottl outcomesofpatientswithstageiiihodgkinlymphomawhohaduniformpretreatmentstagingwithpetctandtreatmentwithlimitedfieldradiationtherapyafterchemotherapy AT stishbradleyj outcomesofpatientswithstageiiihodgkinlymphomawhohaduniformpretreatmentstagingwithpetctandtreatmentwithlimitedfieldradiationtherapyafterchemotherapy AT habermannthomasm outcomesofpatientswithstageiiihodgkinlymphomawhohaduniformpretreatmentstagingwithpetctandtreatmentwithlimitedfieldradiationtherapyafterchemotherapy AT youngjasonr outcomesofpatientswithstageiiihodgkinlymphomawhohaduniformpretreatmentstagingwithpetctandtreatmentwithlimitedfieldradiationtherapyafterchemotherapy AT harmsenwilliams outcomesofpatientswithstageiiihodgkinlymphomawhohaduniformpretreatmentstagingwithpetctandtreatmentwithlimitedfieldradiationtherapyafterchemotherapy AT laacknadian outcomesofpatientswithstageiiihodgkinlymphomawhohaduniformpretreatmentstagingwithpetctandtreatmentwithlimitedfieldradiationtherapyafterchemotherapy |